Document Detail

Prevention of Contrast-Induced Nephropathy With N-Acetylcysteine or Sodium Bicarbonate in Patients With ST-Segment-Myocardial Infarction: A Prospective, Randomized, Open-Labeled Trial.
MedLine Citation:
PMID:  24714489     Owner:  NLM     Status:  Publisher    
BACKGROUND: Contrast-induced nephropathy (CIN) is a serious condition in patients with ST-segment-elevation myocardial infarction treated with primary percutaneous coronary intervention. We compared the risk of acute CIN and the influence of preventive strategies in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
METHODS AND RESULTS: A total of 720 patients were randomized in the Prevention of Contrast-induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (CINSTEMI) trial. Patients were randomly assigned in a 1:1:1:1 ratio to receive hydration with sodium chloride together with 1 of 4 prophylactic regimes (1) N-acetylcysteine (NAC), (2) sodium bicarbonate (NaHCO3) infusion, (3) NAC in combination with NaHCO3, or (4) hydration with sodium chloride infusion alone. Patients in cardiogenic shock were excluded. Acute CIN was defined as an increase in serum creatinine concentration >25% from the baseline value within a 3-day period. Overall, CIN occurred in 141 (21.9%) patients. The prevention treatment with NAC, NaHCO3, or the combined NAC and NaHCO3 did not reduce the rate of CIN significantly compared with hydration with intravenous sodium chloride infusion alone (20.1% versus 20.1% versus 20.8% versus 26.5%; P=NS). However, an increase in serum creatinine >25% from the baseline value to 30 day was significantly lower in patients treated with combined NAC and NaHCO3 (18.7% versus 19.1% versus 9.2% versus 21.3%; P=0.033).
CONCLUSIONS: Treatment with NAC or NaHCO3 did not reduce the rate of acute CIN significantly. Combined treatment with NAC and NaHCO3 may reduce the risk of renal dysfunction after 30 days.
CLINICAL TRIAL REGISTRATION: URL: Unique identifier: NCT01160627.
Per Thayssen; Jens Flensted Lassen; Svend Eggert Jensen; Knud Nørregaard Hansen; Henrik Steen Hansen; Evald Høj Christiansen; Anders Junker; Jan Ravkilde; Leif Thuesen; Karsten Tange Veien; Lisette Okkels Jensen
Related Documents :
2148279 - Effects of intravenous enoximone following coronary artery bypass surgery.
22982779 - Disruption of nox2 and tnfrp55/p75 eliminates cardioprotection induced by anisomycin.
18984759 - Aprotinin for patients exposed to clopidogrel before off-pump coronary bypass.
22585639 - Sudden cardiac death of rhythmic origin in athletes: literature review.
21846649 - Hypocalcaemia-induced transient dilated cardiomyopathy in elderly: a case report.
8957369 - Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dos...
3965649 - Assessment of the site of ventricular activation by fourier analysis of gated blood-poo...
18651009 - Cardiac tamponade and heart failure as a presentation of influenza.
1180569 - Carbon monoxide and heart attacks.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-8
Journal Detail:
Title:  Circulation. Cardiovascular interventions     Volume:  -     ISSN:  1941-7632     ISO Abbreviation:  Circ Cardiovasc Interv     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101499602     Medline TA:  Circ Cardiovasc Interv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Optical Coherence Tomographic Evaluation of Transplant Coronary Artery Vasculopathy With Correlation...
Next Document:  Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western Chi...